Trials / Conditions / Complete Response
Complete Response
6 registered clinical trials studyying Complete Response — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC NCT06811844 | The First Affiliated Hospital of Xiamen University | Phase 2 |
| Not Yet Recruiting | Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study NCT06743555 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 1 |
| Active Not Recruiting | Feasibility of the Maastro Applicator in Rectal Cancer NCT06087718 | Maastricht Radiation Oncology | N/A |
| Completed | Study on the Applicability of CCR Criteria in Rectal Cancer NCT06794099 | Peking University Cancer Hospital & Institute | — |
| Active Not Recruiting | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Respo NCT03522246 | pharmaand GmbH | Phase 3 |
| Active Not Recruiting | Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Ba NCT01844986 | AstraZeneca | Phase 3 |